Display search results for ** instead (33 products)
28 Feb 2014  |  North America
This issue of Vital Signs, released on February 28, 2014, discusses three M&A transactions this month by Nestle, Myriad Genetics, and Fludigm and what these deals mean for the industry. Additionally, Illuminas first stab at personalized medicine through a partnership with Amgen is explored.
02 Jun 2014  |  Global
This issue of Vital Signs, released on June 2, 2014, discusses the latest strategy surrounding mega deals in the pharma/biotech industry, Eurofins agreement to acquire ViroCor-IBT Laboratories, Qiagens acquisition of BIOBASE, and the FDAs latest announcement on regulatory requirements for biosimilars.
01 Jul 2014  |  Global
This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogens Eloctate, Qiagens acquisition of Primera Dx, Roches acquisition of Genia Technologies, Cues at-home connected lab test, and the Credihealth Teen Clinic.
11 Jul 2014  |  Global
Insights into the innovative steps taken by CROs and pharmaceutical companies in the race for excellence and low-cost trials
This issue of Vital Signs, released on July 11, 2014, discusses game changing strategies in clinical research, including virtual clinical research organization (CRO) and the integrated business model.
03 Sep 2014  |  Global
This issue of Vital Signs, released on September 3, 2014, discusses Thermo Fisher Scientifics divestment of laboratory equipment company Cole-Parmer to GTCR, the increasing use of large animal biotechnology in human health applications, the collaboration of Life Technologies and RainTree Oncology Services, the agreement between Ventana and Quintile...
23 Sep 2014  |  North America
The wearables market is currently a center of hype and interest across the varied landscape of consumers, vendors, providers, payers, and other stakeholders interested in the broader digital health market. Companies are trying to better understand consumer habits, exploring device monetization outside of the early adopting fitness crowd, increasing...
03 Oct 2014  |  North America
Electronic cigarettes and vaping products have taken the tobacco industry by storm. Multiple public reports have e-cigarettes surpassing traditional tobacco sales within the next six to ten years if growth rates continue to climb. Due to the lack of Food and Drug Administration (FDA) regulation, e-cigarette year-over-year growth declined from 2010-...
06 Apr 2014  |  North America
Evolving Customer Demands Spurring Competitive Dynamics
Ongoing technology and clinical advances in every imaging modality continue to bring advanced visualization (AV) and clinical applications to centerstage. AV is not just a core step in the interpretation workflow of each of these modalities, but essentially the set of solutions that allows to realize the promises of the advances on the equipment si...
08 Oct 2014  |  North America
Vital Signs - Cardiovascular Imaging and Informatics - 2014 European Society of Cardiology Congress Highlights
2014 ESC Conference Review
As with every cardiology tradeshow today, the show floor of the 2014 European Society of Cardiology (ESC) Congress in Barcelona (Aug. 30-Sept. 3) reserved quite a significant presence for medical imaging. This comes as no surprise, since imaging and informatics continues to reaffirm their role as an important driving force for advancing several are...
11 Jun 2014  |  North America
Value Based Imaging
The concept of value-based imaging is certainly not new, but it has garnered considerable attention from the medical imaging community over the past few years. Confined until recently to the realm of thought leaders at luminary healthcare and advocacy organizations, the concept has gained wide momentum in the past year. Since medical imaging repres...